Applications of stem cell technology in pharmaceutical sciences
The use of stem cell technology to obtain mature human cells has the potential to provide much improved cell culture models for disease modelling and drug discovery. In addition PSCs can provide human cells for ‘cell therapy’, i.e. replacing defective cells or cells that have been lost due to damage or disease. Our group is focussed on developing improved models of brain disease, particularly in relation to neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases. We also work on characterisation of neuronal precursors to select the most appropriate phenotypes for cell therapy.
Enhanced research experiences
The projects are interdisciplinary and involve supervisors from two themes within Monash Institute Pharmaceutical Science. In addition there are opportunities for involvement with collaborators at the University of Melbourne and Monash (Clayton) depending on the project.
Some projects will involve placements in stem cell laboratories outside Monash Institute Pharmaceutical Science. These include laboratories at the University of Melbourne, University of California and Monash Clayton.